Cargando…
Publisher Correction: Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer
Autores principales: | Palazón‑Carrión, Natalia, Jiménez‑Cortegana, Carlos, Sánchez‑León, M. Luisa, Henao‑Carrasco, Fernando, Nogales‑Fernández, Esteban, Chiesa, Massimo, Caballero, Rosalía, Rojo, Federico, Nieto‑García, María‑Adoración, Sánchez‑Margalet, Víctor, de la Cruz‑Merino, Luis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405810/ https://www.ncbi.nlm.nih.gov/pubmed/34462490 http://dx.doi.org/10.1038/s41598-021-96901-8 |
Ejemplares similares
-
Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer
por: Palazón-Carrión, Natalia, et al.
Publicado: (2021) -
Circulating regulatory T cells from breast cancer patients in response to neoadjuvant chemotherapy
por: Sánchez-Margalet, Víctor, et al.
Publicado: (2019) -
Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenalidomide (R2-GDP): Results from the R2-GDP-GOTEL Trial
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2021) -
Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics
por: García-Domínguez, Daniel J., et al.
Publicado: (2022) -
Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study
por: de la Cruz-Merino, Luis, et al.
Publicado: (2021)